TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 3 | -6 | -31 | -35 | -39 | -18 | -21 |
| S | %wins | 0 | 100 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/09 16:30 | 11/12/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Hurvitz Eli | L3 | D | S.d | -13,910 | 10.14 | 10 | -1,372 | -20 | 5,354 | M | 109 | 659 | 163 | 78 | 27 | 21 | -4 | -16 | 3 | -6 | -31 | -35 | -39 | -18 | |
11/13/09 16:30 | 11/12/09 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Hurvitz Eli | L3 | D | M.d | 3 | 0.0010 | 10 | 3,385 | 172 | 5,354 | M | 109 | 659 | 163 | 78 | 27 | 21 | -4 | -16 | 3 | -6 | -31 | -35 | -39 | -18 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |